SYN-TECH Chem. & Pharm. Co., Ltd.

NT$75.90As of Sun 8 Nov 2026, 12:00 UTC
TPEx:1777Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 2.03%
Div yield 5.27%
ROE 13.28%
Biotechnology
Beta (5Y) (0.13)
PE TTM 10.25
TSR TTM 3.97%
Mkt cap NT$3.385B
ROIC 17.59%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$83
9.81%
53.72%
Hold 5|5|11|7|0
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
1.09
1.17
1.23
1.18
7.82%
12.23%
18.61%
3.27%
RevenueNT$M
385.5
383.2
386.3
403.1
16.05%
11.22%
10.19%
10.09%
Peers (US$102.2M)
Cap (US$)
PE
102.3M
—
Capital
TTM
5Y
10Y
Leveragex
1.026
1.843
1.437
EBIT/Intx
0.209
0.219
0.193
Own earn%
2.67
23.42
23.46
Sh yield%
16.56
30.03
28.61
Owners
Insiders/Inst%
11.40
52.72
Short interest%
1.57
SBC / revenue%
2.83
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
25–32
$1 testx
6.2
Incr. ROIC%
2